[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elona  Kogan Esq., J.D.", "age": 55, "title": "Chief Legal Officer", "yearBorn": 1969, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Eric Strauss", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1740787200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.12, "open": 3.1, "dayLow": 2.9, "dayHigh": 3.11, "regularMarketPreviousClose": 3.12, "regularMarketOpen": 3.1, "regularMarketDayLow": 2.9, "regularMarketDayHigh": 3.11, "payoutRatio": 0.0, "beta": -0.312, "forwardPE": -2.1007195, "volume": 551828, "regularMarketVolume": 551828, "averageVolume": 1394526, "averageVolume10days": 850370, "averageDailyVolume10Day": 850370, "bid": 2.89, "ask": 2.96, "bidSize": 5, "askSize": 9, "marketCap": 254908992, "fiftyTwoWeekLow": 2.895, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 3.9047, "twoHundredDayAverage": 6.489775, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -101907920, "profitMargins": 0.0, "floatShares": 53711612, "sharesOutstanding": 87297600, "sharesShort": 5947873, "sharesShortPriorMonth": 5915984, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0681, "heldPercentInsiders": 0.00252, "heldPercentInstitutions": 1.05258, "shortRatio": 5.57, "shortPercentOfFloat": 0.0747, "impliedSharesOutstanding": 87297600, "bookValue": 3.97, "priceToBook": 0.73551637, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -88853000, "trailingEps": -1.12, "forwardEps": -1.39, "enterpriseToEbitda": 1.004, "52WeekChange": -0.58873236, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 2.92, "targetHighPrice": 34.0, "targetLowPrice": 7.5, "targetMeanPrice": 19.0625, "targetMedianPrice": 19.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 358164000, "totalCashPerShare": 4.103, "ebitda": -101552000, "totalDebt": 1347000, "quickRatio": 22.886, "currentRatio": 23.138, "debtToEquity": 0.389, "returnOnAssets": -0.20134, "returnOnEquity": -0.29557, "freeCashflow": -43260376, "operatingCashflow": -70016000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1743197248, "regularMarketTime": 1743192001, "postMarketPrice": 2.92, "postMarketChange": 0.0, "regularMarketChange": -0.19999981, "regularMarketDayRange": "2.9 - 3.11", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1394526, "fiftyTwoWeekLowChange": 0.025000095, "fiftyTwoWeekLowChangePercent": 0.008635611, "fiftyTwoWeekRange": "2.895 - 11.4", "fiftyTwoWeekHighChange": -8.48, "fiftyTwoWeekHighChangePercent": -0.74385965, "fiftyTwoWeekChangePercent": -58.873238, "earningsTimestamp": 1742501100, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.12, "epsForward": -1.39, "epsCurrentYear": -1.1962, "priceEpsCurrentYear": -2.4410634, "fiftyDayAverageChange": -0.98469996, "fiftyDayAverageChangePercent": -0.25218326, "twoHundredDayAverageChange": -3.569775, "twoHundredDayAverageChangePercent": -0.55006146, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -6.4102507, "regularMarketPrice": 2.92, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 0.0, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]